Mathews Journal of Immunology & Allergy

Mathews Journal of Immunology & Allergy (MJIA; ISSN 2575-9523) is a scholarly journal of international repute that publishes peer-reviewed research on key topics, such as the immune system, innate and adaptive immunity, antibody response, T and B lymphocytes, anaphylaxis, primary immune deficiencies, infectious disease, occupational and environmental allergy, allergic rhinitis, food allergy, angioedema, asthma, atopic dermatitis, antihistamines, and monoclonal antibody generation.

MJIA publishes high-impact clinical and translational research manuscripts aimed at immunologists, allergists, and medical professionals and researchers interested in studying clinical immunology and allergic diseases and associated mechanisms. The journal publishes clinical trials and mechanistic studies investigating novel therapies and providing insights into the underlying mechanisms, with special focus on discoveries that will enrich our understanding of immune and allergy related diseases that will ultimately improve the diagnosis and management of patients affected by these conditions. 

MJIA aims to serve as an international forum for showcasing the work of authoritative medical professionals, researchers, and scientists.

Why publish with us?

High Visibility: MJIA follows an open access policy that allows published articles to reach across the globe.
Promotion in Social Media: MJIA promotes articles by providing alerts and regular email updates to subscribers.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.

We welcome all types of articles related to Immunology & Allergy. Please follow the Author Guidelines. For submission assistance contact: i[email protected].

If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.